MSB 5.24% $1.11 mesoblast limited

In this business results are measured by return to shareholders...

  1. 20 Posts.
    lightbulb Created with Sketch. 5

    In this business results are measured by return to shareholders and projected asset/income valuations.
    if not for covid MSB has failed miserably and that is why there is no interest by big pharma or the majority of instituitional investors.

    that said they might get lucky with covid but i think Eswaran's 1 in 3 probability is pretty close.and they have some good research BUT
    translating that into shareholder value is along way off.

    https://www.copyright link/rear-window/somebody-tell-mesoblast-we-get-the-message-20200603-p54z13 is a pretty good summary of
    what most insitutional investors think about Mesoblasts constant hype.

    maybe you are on the MSB hype team. i dont know. i just try to present reality!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.